Asia Pacific Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application (Cloning, Protein Expression, Mutagenesis, and Others), By End-Use, By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Competent Cells Market would witness market growth of 8.5% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Competent Cells Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $304.9 million by 2031. The Japan market is registering a CAGR of 7.9% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 9.3% during (2024 - 2031).

Academic and research laboratories represent significant users of these cells. These institutions rely on these cells for fundamental molecular biology, genetics, and biotechnology research. Adoption in academia is driven by the need for tools that facilitate gene cloning, gene editing, and the construction of genetic libraries for studying gene function and disease mechanisms. Continuous advancements in genetic engineering, synthetic biology, and high-throughput screening technologies drive adoption.

Additionally, competent cell suppliers offer products tailored to specific research and industrial applications. Customization options include specialized strains optimized for high transformation efficiency, protein expression, or specific genetic modifications. This diversity allows researchers to choose products that best meet their experimental requirements.

India’s biotech sector is expanding rapidly, focusing on developing and producing biopharmaceuticals, including vaccines, therapeutic proteins, and biosimilars. As per the National Investment Promotion & Facilitation Agency, India's bioeconomy sector, valued at $137 billion in 2023, is set for significant expansion, with estimates indicating it will reach $150 billion by 2025 and $300 billion by 2030. This growth reflects a strong annual growth rate of 17%. The country boasts formidable capabilities in contract manufacturing, research, and clinical trials, bolstered by the presence of the highest number of US FDA-approved plants globally outside the US.

Additionally, The Chinese government fosters biopharmaceutical innovation through initiatives like the Made in China 2025 strategy and regulatory reforms to streamline drug approval processes. According to the International Trade Administration (ITA), China’s pharmaceutical sector has constantly grown and reached $161.8 billion in 2023, taking about 30% of the global industry share. Suppliers offering compliant and validated competent cell products gain a competitive advantage, supporting local and multinational pharmaceutical firms in achieving regulatory approvals and market entry in China. Thus, the growing biotech and pharmaceutical industries in the region are driving the market's growth.

Free Valuable Insights: The Global Competent Cells Market is Predict to reach USD 3.7 Billion by 2031, at a CAGR of 7.9%

Based on Type, the market is segmented into Chemically Competent Cells, Electrocompetent Cells, and Ultracompetent Cells. Based on Application, the market is segmented into Cloning, Protein Expression, Mutagenesis, and Others. Based on End-Use, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Promega Corporation
• New England Biolabs, Inc.
• Qiagen N.V
• Hoffmann-La Roche Ltd.
• Takara Bio Inc. (Takara Holdings Inc.)
• Lonza Group Ltd. (Capsugel)

Asia Pacific Competent Cells Market Report Segmentation

By Type

• Chemically Competent Cells
• Electrocompetent Cells
• Ultracompetent Cells

By Application

• Cloning
• Protein Expression
• Mutagenesis
• Others

By End-Use

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

By Country

• China
• Japan
• India
• South Korea
• Australia
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Competent Cells Market, by Type
1.4.2 Asia Pacific Competent Cells Market, by Application
1.4.3 Asia Pacific Competent Cells Market, by End-Use
1.4.4 Asia Pacific Competent Cells Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Competent Cells Market
Chapter 5. Asia Pacific Competent Cells Market by Type
5.1 Asia Pacific Chemically Competent Cells Market by Country
5.2 Asia Pacific Electrocompetent Cells Market by Country
5.3 Asia Pacific Ultracompetent Cells Market by Country

Chapter 6. Asia Pacific Competent Cells Market by Application
6.1 Asia Pacific Cloning Market by Country
6.2 Asia Pacific Protein Expression Market by Country
6.3 Asia Pacific Mutagenesis Market by Country
6.4 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Competent Cells Market by End-Use
7.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
7.2 Asia Pacific Academic & Research Institutes Market by Country
7.3 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Competent Cells Market by Country
8.1 China Competent Cells Market
8.1.1 China Competent Cells Market by Type
8.1.2 China Competent Cells Market by Application
8.1.3 China Competent Cells Market by End-Use
8.2 Japan Competent Cells Market
8.2.1 Japan Competent Cells Market by Type
8.2.2 Japan Competent Cells Market by Application
8.2.3 Japan Competent Cells Market by End-Use
8.3 India Competent Cells Market
8.3.1 India Competent Cells Market by Type
8.3.2 India Competent Cells Market by Application
8.3.3 India Competent Cells Market by End-Use
8.4 South Korea Competent Cells Market
8.4.1 South Korea Competent Cells Market by Type
8.4.2 South Korea Competent Cells Market by Application
8.4.3 South Korea Competent Cells Market by End-Use
8.5 Australia Competent Cells Market
8.5.1 Australia Competent Cells Market by Type
8.5.2 Australia Competent Cells Market by Application
8.5.3 Australia Competent Cells Market by End-Use
8.6 Malaysia Competent Cells Market
8.6.1 Malaysia Competent Cells Market by Type
8.6.2 Malaysia Competent Cells Market by Application
8.6.3 Malaysia Competent Cells Market by End-Use
8.7 Rest of Asia Pacific Competent Cells Market
8.7.1 Rest of Asia Pacific Competent Cells Market by Type
8.7.2 Rest of Asia Pacific Competent Cells Market by Application
8.7.3 Rest of Asia Pacific Competent Cells Market by End-Use

Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Merck KGaA
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Trail and Approvals:
9.3.6 SWOT Analysis
9.4 Bio-Rad laboratories, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Promega Corporation
9.5.1 Company Overview
9.5.2 Recent strategies and developments:
9.5.2.1 Partnerships, Collaborations, and Agreements:
9.5.3 SWOT Analysis
9.6 New England Biolabs, Inc.
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Qiagen N.V.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 F. Hoffmann-La Roche Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Takara Bio Inc. (Takara Holdings Inc.)
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.10. Lonza Group Ltd. (Capsugel)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis

TABLE 1 Asia Pacific Competent Cells Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Competent Cells Market, 2024 - 2031, USD Million
TABLE 3 Asia Pacific Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 4 Asia Pacific Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 5 Asia Pacific Chemically Competent Cells Market by Country, 2020 - 2023, USD Million
TABLE 6 Asia Pacific Chemically Competent Cells Market by Country, 2024 - 2031, USD Million
TABLE 7 Asia Pacific Electrocompetent Cells Market by Country, 2020 - 2023, USD Million
TABLE 8 Asia Pacific Electrocompetent Cells Market by Country, 2024 - 2031, USD Million
TABLE 9 Asia Pacific Ultracompetent Cells Market by Country, 2020 - 2023, USD Million
TABLE 10 Asia Pacific Ultracompetent Cells Market by Country, 2024 - 2031, USD Million
TABLE 11 Asia Pacific Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 12 Asia Pacific Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 13 Asia Pacific Cloning Market by Country, 2020 - 2023, USD Million
TABLE 14 Asia Pacific Cloning Market by Country, 2024 - 2031, USD Million
TABLE 15 Asia Pacific Protein Expression Market by Country, 2020 - 2023, USD Million
TABLE 16 Asia Pacific Protein Expression Market by Country, 2024 - 2031, USD Million
TABLE 17 Asia Pacific Mutagenesis Market by Country, 2020 - 2023, USD Million
TABLE 18 Asia Pacific Mutagenesis Market by Country, 2024 - 2031, USD Million
TABLE 19 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 20 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 21 Asia Pacific Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 22 Asia Pacific Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 23 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2020 - 2023, USD Million
TABLE 24 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2024 - 2031, USD Million
TABLE 25 Asia Pacific Academic & Research Institutes Market by Country, 2020 - 2023, USD Million
TABLE 26 Asia Pacific Academic & Research Institutes Market by Country, 2024 - 2031, USD Million
TABLE 27 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 28 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 29 Asia Pacific Competent Cells Market by Country, 2020 - 2023, USD Million
TABLE 30 Asia Pacific Competent Cells Market by Country, 2024 - 2031, USD Million
TABLE 31 China Competent Cells Market, 2020 - 2023, USD Million
TABLE 32 China Competent Cells Market, 2024 - 2031, USD Million
TABLE 33 China Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 34 China Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 35 China Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 36 China Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 37 China Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 38 China Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 39 Japan Competent Cells Market, 2020 - 2023, USD Million
TABLE 40 Japan Competent Cells Market, 2024 - 2031, USD Million
TABLE 41 Japan Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 42 Japan Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 43 Japan Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 44 Japan Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 45 Japan Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 46 Japan Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 47 India Competent Cells Market, 2020 - 2023, USD Million
TABLE 48 India Competent Cells Market, 2024 - 2031, USD Million
TABLE 49 India Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 50 India Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 51 India Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 52 India Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 53 India Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 54 India Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 55 South Korea Competent Cells Market, 2020 - 2023, USD Million
TABLE 56 South Korea Competent Cells Market, 2024 - 2031, USD Million
TABLE 57 South Korea Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 58 South Korea Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 59 South Korea Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 60 South Korea Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 61 South Korea Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 62 South Korea Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 63 Australia Competent Cells Market, 2020 - 2023, USD Million
TABLE 64 Australia Competent Cells Market, 2024 - 2031, USD Million
TABLE 65 Australia Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 66 Australia Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 67 Australia Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 68 Australia Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 69 Australia Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 70 Australia Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 71 Malaysia Competent Cells Market, 2020 - 2023, USD Million
TABLE 72 Malaysia Competent Cells Market, 2024 - 2031, USD Million
TABLE 73 Malaysia Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 74 Malaysia Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 75 Malaysia Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 76 Malaysia Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 77 Malaysia Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 78 Malaysia Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 79 Rest of Asia Pacific Competent Cells Market, 2020 - 2023, USD Million
TABLE 80 Rest of Asia Pacific Competent Cells Market, 2024 - 2031, USD Million
TABLE 81 Rest of Asia Pacific Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 82 Rest of Asia Pacific Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 83 Rest of Asia Pacific Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 84 Rest of Asia Pacific Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 85 Rest of Asia Pacific Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 86 Rest of Asia Pacific Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 87 Key Information – Thermo Fisher Scientific, Inc.
TABLE 88 key Information – Merck KGaA
TABLE 89 key Information – Agilent Technologies, Inc.
TABLE 90 Key Information – Bio-Rad Laboratories, Inc.
TABLE 91 key Information – Promega Corporation
TABLE 92 Key Information – New England BioLabs, Inc.
TABLE 93 Key Information – Qiagen N.V.
TABLE 94 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 95 Key Information – Takara Bio Inc.
TABLE 96 Key Information –Lonza Group Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Competent Cells Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Competent Cells Market
FIG 4 Porter’s Five Forces Analysis – Competent Cells Market
FIG 5 Asia Pacific Competent Cells Market share by Type, 2023
FIG 6 Asia Pacific Competent Cells Market share by Type, 2031
FIG 7 Asia Pacific Competent Cells Market by Type, 2020 - 2031, USD Million
FIG 8 Asia Pacific Competent Cells Market share by Application, 2023
FIG 9 Asia Pacific Competent Cells Market share by Application, 2031
FIG 10 Asia Pacific Competent Cells Market by Application, 2020 - 2031, USD Million
FIG 11 Asia Pacific Competent Cells Market share by End-Use, 2023
FIG 12 Asia Pacific Competent Cells Market share by End-Use, 2031
FIG 13 Asia Pacific Competent Cells Market by End-Use, 2020 - 2031, USD Million
FIG 14 Asia Pacific Competent Cells Market share by Country, 2023
FIG 15 Asia Pacific Competent Cells Market share by Country, 2031
FIG 16 Asia Pacific Competent Cells Market by Country, 2020 - 2031, USD Million
FIG 17 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 18 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 19 Swot Analysis: Merck KGaA
FIG 20 Swot Analysis: Agilent Technologies, Inc.
FIG 21 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 22 Swot Analysis: Promega Corporation
FIG 23 Swot Analysis: New England Biolabs Inc.
FIG 24 Swot Analysis: Qiagen N.V.
FIG 25 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 26 Swot Analysis: Lonza Group Ltd.